Northern Trust’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-317,526
| Closed | -$34.1M | – | 4621 |
|
|
2023
Q1 | $34.1M | Buy |
317,526
+9,486
| +3% | +$1.02M | 0.01% | 1200 |
|
|
2022
Q4 | $33.9M | Buy |
308,040
+46,438
| +18% | +$5.11M | 0.01% | 1180 |
|
|
2022
Q3 | $15.4M | Buy |
261,602
+37,440
| +17% | +$2.21M | ﹤0.01% | 1678 |
|
|
2022
Q2 | $6.33M | Sell |
224,162
-2,443
| -1% | -$69K | ﹤0.01% | 2349 |
|
|
2022
Q1 | $8.56M | Sell |
226,605
-3,595
| -2% | -$136K | ﹤0.01% | 2243 |
|
|
2021
Q4 | $9.1M | Buy |
230,200
+129,174
| +128% | +$5.11M | ﹤0.01% | 2298 |
|
|
2021
Q3 | $2.4M | Sell |
101,026
-9,712
| -9% | -$230K | ﹤0.01% | 3191 |
|
|
2021
Q2 | $2.72M | Buy |
+110,738
| New | +$2.72M | ﹤0.01% | 3207 |
|